Dark

DOCS
Doximity, Inc.
stock NYSE

At Close

May 16, 2025 3:59:30 PM EDT

52.56USD-10.077%(-5.89)17,808,016

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:28:30 AM EDT

48.00USD-17.879%(-10.45)723,914

After-hours

May 16, 2025 4:55:30 PM EDT

52.32USD-0.464%(-0.24)23,884

OverviewOptionsHistoricalExchangesShortsNews

Jan 18, 2022

04:01PM EST Doximity to Release Fiscal 2022 Third Quarter Results on February 8, 2022 PR Newswire

Dec 17, 2021

09:09AM EST Morgan Stanley Maintains Equal-Weight on Doximity, Lowers Price Target to $58 Benzinga

Dec 16, 2021

11:29AM EST California-based e-healthcare platform, Doximity, Inc. (DOCS) has again turned to a fall in the market as the shares drop another 7% on Thursday. The company has not posted any stock-related news to attribute to the fall. RTTNews

09:02AM EST Doximity Releases New Study On Physician Compensation and COVID-Related PR Newswire

Dec 14, 2021

10:03AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2021 Benzinga

05:15AM EST JP Morgan Downgrades Doximity to Underweight, Lowers Price Target to $60 Benzinga

Dec 2, 2021

11:22AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2021 Benzinga

11:14AM EST Where Doximity Stands With Analysts Benzinga

04:56AM EST Jefferies Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $78 Benzinga

Nov 17, 2021

04:02PM EST Doximity to Participate in Upcoming Investor Events PR Newswire

10:04AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021 Benzinga

05:10AM EST Baird Initiates Coverage On Doximity with Outperform Rating, Announces Price Target of $84 Benzinga

Nov 10, 2021

12:21PM EST Expert Ratings For Doximity Benzinga

09:14AM EST Raymond James Maintains Outperform on Doximity, Raises Price Target to $80 Benzinga

06:49AM EST Needham Maintains Buy on Doximity, Raises Price Target to $90 Benzinga

06:38AM EST SVB Leerink Maintains Outperform on Doximity, Raises Price Target to $72 Benzinga

Nov 9, 2021

06:28PM EST Doximity Q2 EPS $0.19 Beats $0.10 Estimate, Sales $79.35M Beat $73.50M Estimate Benzinga

06:28PM EST Doximity Sees Q3 Sales $85.8M-$86.8M Vs. $74.66M Est., FY22 Sales $326.1M-$328.1M Vs. $299.41M Est. Benzinga

04:10PM EST Doximity Announces Fiscal 2022 Second Quarter Financial Results PR Newswire

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Oct 19, 2021

04:01PM EDT Doximity to Release Fiscal 2022 Second Quarter Results on November 9, 2021 PR Newswire

Sep 26, 2021

04:31PM EDT Cramer Gives His Opinion On Carnival Corp, Doximity And More Benzinga

Sep 15, 2021

07:47AM EDT Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring Benzinga

Aug 31, 2021

12:37PM EDT Analyst Ratings For Doximity Benzinga

07:38AM EDT Morgan Stanley Maintains Equal-Weight on Doximity, Raises Price Target to $71 Benzinga

Aug 26, 2021

11:01AM EDT Doximity Announces 2021-2022 Residency Navigator PR Newswire

10:28AM EDT Doximity, Inc. (DOCS) shares are sliding more than 8 percent on Thursday morning trade after reaching a year-to-date high yesterday. There were no corporate announcements from the company to impact the stock movement. RTTNews

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021 Benzinga

05:39AM EDT JP Morgan Downgrades Doximity to Neutral, Announces $70 Price Target Benzinga

Aug 23, 2021

04:15PM EDT Doximity to Participate in a Virtual Fireside Chat at Morgan Stanley's 19th PR Newswire

Aug 21, 2021

12:29PM EDT Expert Ratings For Doximity Benzinga

Aug 12, 2021

10:17AM EDT Mid-Morning Market Update: Markets Down; US Producer Prices Rise 1% In July Benzinga

Aug 11, 2021

12:29PM EDT What 9 Analyst Ratings Have To Say About Doximity Benzinga

10:37AM EDT Doximity, Inc. (DOCS) shares are rising more than 21 percent on Wednesday morning trade after the company reported 36 percent growth in second quarter net profit supported by nearly double increase in revenues. RTTNews

07:25AM EDT Raymond James Maintains Outperform on Doximity, Raises Price Target to $62 Benzinga

Aug 10, 2021

04:58PM EDT CORRECTION: Doximity Sees Q2 Sales $73M-$74M Benzinga

04:58PM EDT Doximity Sees Q2 Sales $73M-$74M, FY21 Sales $296.5M-$299.5M Benzinga

04:46PM EDT Doximity Q1 EPS $0.11 Beats $0.08 Estimate, Sales $72.70M Beat $63.41M Estimate Benzinga

04:15PM EDT Doximity Announces Fiscal 2022 First Quarter Financial Results PR Newswire

04:05AM EDT Earnings Scheduled For August 10, 2021 Benzinga

Aug 6, 2021

11:00AM EDT Doximity Shares Down ~5%, Traders Circulate CNBC Report Titled, 'The social network for doctors is full of vaccine disinformation' Benzinga

Jul 20, 2021

04:05PM EDT Doximity to Release Fiscal 2022 First Quarter Results on August 10, 2021 PR Newswire

Jul 19, 2021

10:13AM EDT UPDATE: Needham On Doximity Buy Initiation: Firm Sees Co. Well-Positioned In Fast Growing SaaS & Digital Health Sectors; Highlights Pandemic Creating 'Great Thirst For Digital Marketing Solutions' Coupled With Telehealth To Drive Upside Consensus Growth Benzinga

10:10AM EDT UPDATE: Morgan Stanley On Doximity Equal-Weight Initiation: Co.'s Subscription Platforms Generate Sticky Revenues From Pharma And Health Systems Driving A 25% Top Line Growth Rate Through 2023e, However, Trading At A 5.8X Turn Premium Leaves Firm At EW Benzinga

10:03AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2021 Benzinga

09:07AM EDT Morgan Stanley Initiates Coverage On Doximity with Equal-Weight Rating, Announces Price Target of $52 Benzinga

08:22AM EDT Raymond James Initiates Coverage On Doximity with Outperform Rating, Announces Price Target of $60 Benzinga

08:14AM EDT Needham Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $62 Benzinga

07:32AM EDT William Blair Initiates Coverage On Doximity with Outperform Rating Benzinga

07:31AM EDT Canaccord Genuity Initiates Coverage On Doximity with Buy Rating, Announces Price Target of $64 Benzinga

06:36AM EDT SVB Leerink Initiates Coverage On Doximity with Outperform Rating, Announces Price Target of $65 Benzinga

06:22AM EDT Piper Sandler Initiates Coverage On Doximity with Overweight Rating, Announces Price Target of $68 Benzinga

06:20AM EDT Goldman Sachs Initiates Coverage On Doximity with Neutral Rating, Announces Price Target of $36 Benzinga

05:20AM EDT JP Morgan Initiates Coverage On Doximity with Overweight Rating, Announces Price Target of $60 Benzinga

Jul 9, 2021

11:19AM EDT Shares of recently-listed California-based tech company Doximity Inc (DOCS) gained 8% on Friday morning. The company has not announced anything stock-related news to drive the shares up. RTTNews

Jul 5, 2021

07:25AM EDT Notable Insider Buys In The Past Week: Asana, Transocean, IPOS, SPACS And More Benzinga

Jun 24, 2021

01:18PM EDT Doximity Shares Open For Trade At $41.17; IPO Priced At $26/Share Benzinga

12:53PM EDT Doximity Indicating $40-$40.10 On 2.5M Shares Benzinga

11:49AM EDT Doximity Indicating $36-$37 Benzinga

09:20AM EDT Doximity Shares Expected To Open For Trade Today; IPO Priced At $26/Share Benzinga

08:35AM EDT Benzinga Pro's Top 5 Stocks To Watch For Thursday, Jun. 24, 2021: DKNG, ROKU, UPS, DOCS, ENTX Benzinga

07:47AM EDT HealthCare Platform Doximity Prices Upsized IPO At $26/Share; Trading Begins Today Benzinga

07:44AM EDT HealthCare Provider Doximity Prices Upsized IPO At $26/Share; Trading Begins Today Benzinga

Jun 23, 2021

06:01PM EDT Doximity Initial Public Offering To Be Priced At $26/Share Benzinga

06:00PM EDT Doximity Announces Pricing of Initial Public Offering PR Newswire

.dark-mode .YhXjck{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .YhXjck{ color: #333333; background-color: white; border: 2px solid #333333; }DOCSDoximity, Inc.stock NYSE

DOCS
Doximity, Inc.
stock NYSE